Large-scale testing (Phase 3)Study completedNCT02013037
What this trial is testing
The De-novo Use of Eculizumab in Presensitized Patients Receiving Cardiac Transplantation
Who this might be right for
Antibody-mediated RejectionHyperacute Rejection of Cardiac TransplantLeft Ventricular Dysfunction+2 more
Cedars-Sinai Medical Center 36